Loading…
CalciMedica, Inc. is projected to rise to $1.21 by 2027, a +61% move from its current price of $0.7527. CALC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.699 | $0.7542 | $0.8136 | +0.19% |
| Aug 6 | $0.6787 | $0.7556 | $0.8413 | +0.39% |
| Aug 7 | $0.6638 | $0.7571 | $0.8635 | +0.58% |
| Aug 8 | $0.6517 | $0.7585 | $0.8829 | +0.77% |
| Aug 9 | $0.6413 | $0.76 | $0.9006 | +0.97% |
| Aug 10 | $0.6322 | $0.7615 | $0.9171 | +1.16% |
| Aug 11 | $0.6241 | $0.7629 | $0.9327 | +1.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6241 | $0.7629 | $0.9327 | +1.36% |
| Week 2 | $0.582 | $0.7733 | $1.03 | +2.73% |
| Week 3 | $0.5534 | $0.7838 | $1.11 | +4.13% |
| Week 4 | $0.5316 | $0.7944 | $1.19 | +5.54% |
| Week 5 | $0.5138 | $0.8052 | $1.26 | +6.98% |
| Week 6 | $0.4989 | $0.8161 | $1.33 | +8.43% |
| Week 7 | $0.4862 | $0.8272 | $1.41 | +9.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company in Healthcare that develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.
The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
CALC is a Healthcare stock currently priced at $1.00 with a market cap of $15.8M, ranking 4944. This places it among smaller-cap names in the sector, with a price that has recently traded within a defined framework.
Technically, the stock carries a bullish tilt in sentiment, with RSI(14) at 60 and moving averages at SMA50 $0.8233 and SMA200 $2.03. Near-term support stands at $0.597 and resistance at $1.04, framing a narrow range around the current level.
The 30-day price range runs from $0.6062 to $1.65, and annualized volatility sits at 100%. The forecasted path shows multiple-year targets, with 2026 avg $1.00, 2027 avg $1.60, 2028 avg $1.74, 2029 avg $2.10, and 2030 avg $1.88, progressing to 2031 avg $2.16, 2032 avg $3.62, 2033 avg $4.26, 2034 avg $4.44, 2035 avg $4.44, then a substantial rise to 2040 avg $8.84 and 2050 avg $19.08.
A major floor 42.1% below — a decisive break under it would weaken the trend.
The nearest floor, 20.7% below — buyers have tended to step in here.
The nearest ceiling, 38.2% above — a clean break opens room to run.
A major ceiling 75.6% above — clearing it would confirm fresh momentum.
Key CALC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CALC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8008 | Sell | $0.8447 | Sell |
| MA 10 | $0.7639 | Sell | $0.8051 | Sell |
| MA 20 | $0.8068 | Sell | $0.8022 | Sell |
| MA 50 | $0.8233 | Sell | $0.8171 | Sell |
| MA 100 | $0.7294 | Buy | $1.04 | Sell |
| MA 200 | $2.03 | Sell | $1.56 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.03 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 138.88 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 27.88 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 71.57 | Sell |
| Momentum (10) | 0.26 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 0.86 | Sell |
| ADX (14) | 13.68 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish overall, reflecting positive near-term momentum.
RSI(14) is 60, which sits in the upper-neutral to bullish range and suggests room for a continuation of upside moves. The near-term trend is framed by the SMA50 at $0.8233 and the SMA200 at $2.03, with a near-term support of $0.597 and resistance at $1.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.507 | $0.7527 | $1.24 | 0% | Neutral | |
| $0.8853 | $1.21 | $1.80 | +61% | Bullish | |
| $0.9079 | $1.33 | $2.10 | +76% | Bullish | |
| $1.04 | $1.60 | $2.66 | +112% | Bullish | |
| $0.8917 | $1.44 | $2.49 | +91% | Bullish | |
| $0.9796 | $1.65 | $2.96 | +119% | Bullish | |
| $1.58 | $2.78 | $5.13 | +269% | Bullish | |
| $1.80 | $3.30 | $6.26 | +338% | Bullish | |
| $1.80 | $3.44 | $6.70 | +356% | Bullish | |
| $1.73 | $3.43 | $6.83 | +355% | Bullish | |
| $3.10 | $6.89 | $15.11 | +815% | Bullish | |
| $6.73 | $14.95 | $34.38 | +18.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.507 | $0.7527 | $1.01 | +0.00% |
| September 2026 | $0.7391 | $0.8984 | $1.14 | +19.36% |
| October 2026 | $0.728 | $0.8973 | $1.16 | -0.12% |
| November 2026 | $0.7024 | $0.8756 | $1.15 | -2.41% |
| December 2026 | $0.7369 | $0.9283 | $1.24 | +6.01% |
Click any year to see its month-by-month CALC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CALC could reach as high as $1.24, with a base case around $0.7527 and support toward $0.507 — roughly 0% from $0.7527. Price action looks broadly range-bound.
Expect CALC to range from $0.8853 to $1.80 through 2027. The $1.21 average target implies a +61% move from current prices. That is up +61% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CALC price prediction for 2028 points to an average of $1.33 (low $0.9079, high $2.10) — a potential gain of +76% on today's $0.7527. Momentum favours further upside here.
In 2029, CALC is projected to trade between $1.04 and $2.66, averaging $1.60 — a potential gain of +112% from today's $0.7527. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
CalciMedica, Inc.'s 2030 outlook centres on $1.44, within a $0.8917 to $2.49 range. That is -10% versus the projected 2029 average. That marks a +91% change versus current levels. Momentum favours further upside here.
By 2031, CALC could reach as high as $2.96, with a base case around $1.65 and support toward $0.9796 — roughly +119% from $0.7527. Buyers look set to stay in control over this stretch.
Expect CALC to range from $1.58 to $5.13 through 2032. The $2.78 average target implies a +269% move from current prices. That is up +68% on the projected 2031 average. Momentum favours further upside here.
The CALC price prediction for 2033 points to an average of $3.30 (low $1.80, high $6.26) — a potential gain of +338% on today's $0.7527. Buyers look set to stay in control over this stretch.
In 2034, CALC is projected to trade between $1.80 and $6.70, averaging $3.44 — a potential gain of +356% from today's $0.7527. That is up +4% on the projected 2033 average. Momentum favours further upside here.
CalciMedica, Inc.'s 2035 outlook centres on $3.43, within a $1.73 to $6.83 range. That is 0% versus the projected 2034 average. That marks a +355% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CALC could reach as high as $15.11, with a base case around $6.89 and support toward $3.10 — roughly +815% from $0.7527. Momentum favours further upside here.
Expect CALC to range from $6.73 to $34.38 through 2050. The $14.95 average target implies a +18.9x move from current prices. That is up +117% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CALC today (≈ 1,328.550551 CALC) could be worth
$19,857.05
+$18,857.05 (+1886%) by 2050 · US Dollar
Based on the average projected CALC price of $14.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CALCwould be worth at today's price.
$1,000 invested in CALC on Jul 31, 2025 (≈ 290.69767 CALC) would be worth
$218.81
-$781.19 (-78.1%) today · 0.22× · US Dollar
Based on a CALC entry price of $3.44 vs. today's $0.7527.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.76 | $990.39 | -1.0% |
| 1 month ago | $1.04 | $723.75 | -27.6% |
| 3 months ago | $0.589 | $1,277.93 | +27.8% |
| 6 months ago | $0.67 | $1,123.43 | +12.3% |
| 1 year ago | $3.44 | $218.81 | -78.1% |
| All time (3.1y) ago | $5.84 | $128.89 | -87.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CALC forecast.
Our base-case forecast reaches $1.50 around 2029.
Implied market cap at $1.50: $23.7M
The multi-year forecast depicts a bullish trajectory across the horizon, with steady upside in the averages and rising confidence in later years. Notably, 2030 shows an avg of $1.88 with a 87.8 ROI, 2040 shows an avg of $8.84 with a 784.3 ROI, and 2050 shows an avg of $19.08 with a 1808 ROI, underscoring the potential scale of upside over time.
Additional milestones appear in the mid-2030s, with 2032 avg $3.62 and 2033 avg $4.26 (ROIs 262 and 326.3, respectively), followed by continued growth through 2034–2035 (avg $4.44, ROI 344–344.3). The forecast reinforces substantial long-run upside, albeit with the inherent uncertainty of future price projections and the stock’s volatility profile (annualized volatility at 100%).
Tap a question to reveal the answer.
The forecast for 2030 shows an avg price of $1.88 with a ROI of 87.8 and a bullish sentiment.
The forecast shows bullish sentiment in multiple years with strong upside, including 2040 avg $8.84 (ROI 784.3) and 2050 avg $19.08 (ROI 1808), though 2026 is neutral.
Yes. The max values indicate CALC could exceed $10 by 2040 ($19.39) and 2050 ($43.88), while earlier years' maxes are lower (e.g., 2033 max $8.10).
Current price is $1.00 and market cap is $15.8M.
Near-term indicators show bullish sentiment with RSI(14) at 60, SMA50 at $0.8233, SMA200 at $2.03, a support level of $0.597, a resistance at $1.04, and a 30-day range from $0.6062 to $1.65.
CalciMedica, Inc. Community Discussion
0Share your CalciMedica, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.